Sirona Biochem (Seite 742)
eröffnet am 23.06.13 12:55:10 von
neuester Beitrag 24.05.24 19:03:38 von
neuester Beitrag 24.05.24 19:03:38 von
Beiträge: 31.056
ID: 1.183.167
ID: 1.183.167
Aufrufe heute: 76
Gesamt: 5.407.493
Gesamt: 5.407.493
Aktive User: 0
ISIN: CA82967M1005 · WKN: A0RM6R · Symbol: ZSB
0,0395
EUR
+1,28 %
+0,0005 EUR
Letzter Kurs 09:43:19 Tradegate
Neuigkeiten
| TitelBeiträge |
|---|
07.05.24 · IRW Press |
07.05.24 · globenewswire  |
08.04.24 · globenewswire |
05.04.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 4,9600 | +41,71 | |
| 5,3000 | +28,64 | |
| 1,3000 | +26,21 | |
| 1,1000 | +22,22 | |
| 16,550 | +14,14 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,1200 | -18,46 | |
| 2,1000 | -18,60 | |
| 9,6000 | -18,64 | |
| 1,4600 | -24,56 | |
| 1,7000 | -31,17 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 66.810.673 von Santana123 am 04.02.21 07:52:12
$
sofern $ = Dollar und nicht $ = C$ 
Antwort auf Beitrag Nr.: 66.809.329 von Geheimnisvoller am 04.02.21 00:13:57
allein der Preis ist schon interessant
" $0.38 per common share" umgerechnet sind das ca. 0,32 Euro , man geht also von steigenden Kursen aus
Zitat von Geheimnisvoller: .... stock options to independent directors and consultants of the Company.
Tja, immer dasselbe und fraglich sinnvoll für uns Aktionäre.
allein der Preis ist schon interessant
" $0.38 per common share" umgerechnet sind das ca. 0,32 Euro , man geht also von steigenden Kursen aus
Antwort auf Beitrag Nr.: 66.809.329 von Geheimnisvoller am 04.02.21 00:13:57Ich frage mich, ob es in ein paar Stunden eine weitere News geben wird.?!
.... stock options to independent directors and consultants of the Company.
Tja, immer dasselbe und fraglich sinnvoll für uns Aktionäre.
Tja, immer dasselbe und fraglich sinnvoll für uns Aktionäre.
Sirona Newsletter:
Sirona Biochem Announces Grant of Stock Options
Vancouver, British Columbia – February 3, 2021 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that it has granted an aggregate of 350,000 incentive stock options to independent directors and consultants of the Company. The options, to purchase common shares in the capital of the Company at a price of $0.38 per common share, will be for periods ranging from 1 to 5 years. The options have been granted under the terms of the Company’s stock option plan.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information regarding this press release, please contact:
Investor Enquiries:
Jonathan Williams
Managing Director
Momentum PR
Phone: 1.450.332.6939
Email: jwilliams@momentumpr.com
Sirona Biochem Announces Grant of Stock Options
Vancouver, British Columbia – February 3, 2021 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that it has granted an aggregate of 350,000 incentive stock options to independent directors and consultants of the Company. The options, to purchase common shares in the capital of the Company at a price of $0.38 per common share, will be for periods ranging from 1 to 5 years. The options have been granted under the terms of the Company’s stock option plan.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information regarding this press release, please contact:
Investor Enquiries:
Jonathan Williams
Managing Director
Momentum PR
Phone: 1.450.332.6939
Email: jwilliams@momentumpr.com
Trading Spotlight
Sirona Biochem Announces Grant of Stock Options
Vancouver, British Columbia – February 3, 2021 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that it has granted an aggregate of 350,000 incentive stock options to independent directors and consultants of the Company. The options, to purchase common shares in the capital of the Company at a price of $0.38 per common share, will be for periods ranging from 1 to 5 years. The options have been granted under the terms of the Company’s stock option plan.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information regarding this press release, please contact:
Investor Enquiries:
Jonathan Williams
Managing Director
Momentum PR
Phone: 1.450.332.6939
Email: jwilliams@momentumpr.com
Vancouver, British Columbia – February 3, 2021 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) announces that it has granted an aggregate of 350,000 incentive stock options to independent directors and consultants of the Company. The options, to purchase common shares in the capital of the Company at a price of $0.38 per common share, will be for periods ranging from 1 to 5 years. The options have been granted under the terms of the Company’s stock option plan.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information regarding this press release, please contact:
Investor Enquiries:
Jonathan Williams
Managing Director
Momentum PR
Phone: 1.450.332.6939
Email: jwilliams@momentumpr.com
Der Countdown läuft ...
https://www.sironabiochem.com/wp-content/uploads/2021/02/SBM…
Warten ist manchmal eine Tugend ...
https://www.sironabiochem.com/wp-content/uploads/2021/02/SBM…
Warten ist manchmal eine Tugend ...
Antwort auf Beitrag Nr.: 66.793.099 von hmW am 03.02.21 11:24:42Ergebnisse sollten im Februar vorhanden sein. Bzgl. Veröffentlichung gehe ich davon aus dass man sich ganz in Sirona-Art völlig dem großen Partner ausgeliefert hat und der bestimmt ob und wann etwas veröffetlicht wird..
The study is expected to complete in early 2021 with results in February 2021. The study protocol was established through a collaboration of the scientific teams of TFChem, Sirona’s wholly owned subsidiary and the Company’s skincare scientific team.
Following the study, the Company will have first access to the clinical study results to assess potential use by its subsidiary dermatology company.
https://www.sironabiochem.com/sirona-biochem-signs-agreement…
The study is expected to complete in early 2021 with results in February 2021. The study protocol was established through a collaboration of the scientific teams of TFChem, Sirona’s wholly owned subsidiary and the Company’s skincare scientific team.
Following the study, the Company will have first access to the clinical study results to assess potential use by its subsidiary dermatology company.
https://www.sironabiochem.com/sirona-biochem-signs-agreement…
Antwort auf Beitrag Nr.: 66.794.257 von Hrubesch09 am 03.02.21 12:10:19?Fragenüberfragen?
Antwort auf Beitrag Nr.: 66.793.099 von hmW am 03.02.21 11:24:42
2022
Die kommenden Feiertage sind noch im Weg, Fragen? 
Durchsuchen
Sirona Biochem
